# Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma

> **NCT06330337** · PHASE3 · RECRUITING · sponsor: **The Third Affiliated hospital of Zhejiang Chinese Medical University** · enrollment: 58 (estimated)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** Temozolomide（TMZ） injection or oral administration
- **DRUG:** Albumin-Bound Paclitaxel(ABX) intravenous drip
- **DEVICE:** Specific mode electroacupuncture stimulation(SMES) intervention

## Key facts

- **NCT ID:** NCT06330337
- **Lead sponsor:** The Third Affiliated hospital of Zhejiang Chinese Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2024-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06330337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06330337, "Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06330337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*